Reactive oxygen species and mitochondrial oxidative stress pathways (ROS/mOS pathways)

Reactive oxygen species (ROS) and mitochondrial oxidative stress pathways represent a complex network of biochemical reactions involving oxygen-derived free radicals produced primarily during mitochondrial oxidative phosphorylation (NIH, 2023). While physiological levels of ROS act as essential secondary messengers in signal transduction and gene expression, excessive accumulation—often due to mitochondrial dysfunction—leads to oxidative stress, causing irreversible damage to cellular macromolecules like DNA, proteins, and lipids (PubMed, PMID: 30268768). This pathway is a critical driver in the progression of aging and various chronic conditions, including neurodegenerative diseases (e.g., Parkinson's), cardiovascular diseases, and metabolic syndromes (StatPearls, 2023). Pharmacological intervention typically involves the use of antioxidants to scavenge radicals, Nrf2 activators to boost endogenous defenses, or mitochondria-targeted molecules like MitoQ to localize protective effects (Nature Reviews Drug Discovery, 2014). However, therapeutic development is challenged by the "antioxidant paradox," where non-selective ROS depletion can interfere with vital cellular processes such as immune response and apoptosis (Wikipedia, 2024). Consequently, precision in targeting specific ROS sources or downstream effectors remains a major focus in drug discovery to avoid disrupting essential redox homeostasis.

Other names

Mitochondrial ROS productionOxidative stress signalingRedox signaling pathwaysMitochondrial dysfunction pathwaysOxidative phosphorylation-derived stress

Direct scavenging of reactive oxygen species, induction of the Nrf2-ARE antioxidant signaling pathway, and inhibition of mitochondrial permeability transition pore (mPTP) opening.